EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of SOX10 on the proliferative, invasive, migratory, and epithelial–mesenchymal transition abilities of triple-negative breast cancer cells

Shuai Wang, Linfang Jin

Frontiers in Oncology · 18.05.2026 · 16

DOI: 10.3389/fonc.2026.1769833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 18.05.2026. Verfasst von Shuai Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Wuxi Ninth People's Hospital Affiliated to Soochow University/Wuxi Orthopedic Institute, Wuxi, Jiangsu, China. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer with limited targeted therapeutic options. Sry-related HMG-box gene 10 (SOX10) has been implicated in tumor progression in various malignancies, but its functional role and underlying mechanism in TNBC remain unclear. This study aimed to investigate the effect of SOX10 on TNBC cell proliferation, metastasis, and epithelial–mesenchymal transition (EMT), and to explore its association with the Wnt/β-catenin signaling pathway.

Methods

HCC1937 cells (high endogenous SOX10 expression) and MDA-MB-453 cells (low endogenous SOX10 expression) were used for SOX10 knockdown and overexpression experiments. Wnt pathway activators and inhibitors were applied in rescue experiments to validate the mechanistic link. Cell proliferation was assessed by CCK-8 assay; migration and invasion were evaluated by scratch wound and Transwell assays, respectively. The expression levels of EMT markers and Wnt/β-catenin pathway-related proteins were quantified by Western blot analysis.

Results

SOX10 overexpression significantly promoted proliferation, migration, and invasion in both TNBC cell lines, while SOX10 knockdown markedly inhibited these abilities (all P<0.05). SOX10 upregulated the expression of mesenchymal markers (Vimentin, N-cadherin) and Wnt/β-catenin pathway components (WNT1, nuclear β-catenin, C-myc, Cyclin D1), and downregulated the epithelial marker E-cadherin (all P<0.05). Rescue experiments confirmed that Wnt pathway activation reversed the EMT suppression induced by SOX10 knockdown, while Wnt pathway inhibition attenuated the EMT promotion caused by SOX10 overexpression (all P<0.05).

Discussion

SOX10 promotes malignant biological behaviors in TNBC cells by activating the Wnt/β-catenin signaling pathway and inducing EMT. These findings suggest that the SOX10-Wnt/β-catenin axis may serve as a potential therapeutic target for TNBC, warranting further mechanistic and translational investigation.

Schlagwörter

Stichwörter der Autor:innen

SOX10Wnt/β-catenin pathwaycellular biological behaviorepithelial-mesenchymal transitiontriple negative breast cancer

Autor:innen und Institutionen

  • Wuxi Ninth People's Hospital Affiliated to Soochow University/Wuxi Orthopedic Institute, Wuxi, Jiangsu, China.

Zitieren

APA

Wang, S., & Jin, L. (2026). Effects of SOX10 on the proliferative, invasive, migratory, and epithelial–mesenchymal transition abilities of triple-negative breast cancer cells. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1769833

Vancouver

Wang S, Jin L. Effects of SOX10 on the proliferative, invasive, migratory, and epithelial–mesenchymal transition abilities of triple-negative breast cancer cells. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1769833

BibTeX
@article{Wang2026,
  author = {Wang, Shuai and Jin, Linfang},
  title = {Effects of SOX10 on the proliferative, invasive, migratory, and epithelial–mesenchymal transition abilities of triple-negative breast cancer cells},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1769833}
}
Kostenlos starten →